Literature DB >> 12675125

Allosteric drugs acting at muscarinic acetylcholine receptors.

Magali Waelbroeck1.   

Abstract

The binding properties of muscarinic acetylcholine receptors are affected by various drugs acting at a second (allosteric) binding site, usually (but not always) at supratherapeutic concentrations. Allosteric drugs acting at GABA receptors present advantages over competitive drugs; this explains the interest raised by allosteric effects on muscarinic receptors. A theoretical and practicable definition of allosteric drugs acting at muscarinic receptors will be given in this work, together with a summary of recent data concerning the number, position, and structural requirements of their binding sites.

Mesh:

Substances:

Year:  2003        PMID: 12675125     DOI: 10.1023/a:1022888332221

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

Review 1.  A new benzodiazepine pharmacology.

Authors:  H Möhler; J M Fritschy; U Rudolph
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.

Authors:  Stefan Buller; Darius Paul Zlotos; Klaus Mohr; John Ellis
Journal:  Mol Pharmacol       Date:  2002-01       Impact factor: 4.436

3.  Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-di benzo[b,e][1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes.

Authors:  J Ellis; M Seidenberg
Journal:  Biochem Pharmacol       Date:  1999-01-15       Impact factor: 5.858

4.  Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

Authors:  A L Gnagey; M Seidenberg; J Ellis
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

5.  Positive and negative allosteric interactions on muscarinic receptors.

Authors:  L Hejnová; S Tucek; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1995-11-30       Impact factor: 4.432

6.  Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.

Authors:  N H Lee; J Hu; E E el-Fakahany
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

7.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.

Authors:  J Proska; S Tucek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

8.  Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.

Authors:  A Maass; K Mohr
Journal:  Eur J Pharmacol       Date:  1996-06-03       Impact factor: 4.432

9.  Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.

Authors:  L T Potter; C A Ferrendelli; H E Hanchett; M A Hollifield; M V Lorenzi
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

10.  Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.

Authors:  E H Gerstin; T Luong; F J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

View more
  1 in total

1.  Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

Authors:  Carrie K Jones; Ashley E Brady; Albert A Davis; Zixiu Xiang; Michael Bubser; Mohammed Noor Tantawy; Alexander S Kane; Thomas M Bridges; J Phillip Kennedy; Stefania R Bradley; Todd E Peterson; M Sib Ansari; Ronald M Baldwin; Robert M Kessler; Ariel Y Deutch; James J Lah; Allan I Levey; Craig W Lindsley; P Jeffrey Conn
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.